Sectoral Asset Management Inc.
Latest statistics and disclosures from SECTORAL ASSET MANAGEMENT's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MRK, JNJ, PFE, NBIX, NVS, and represent 23.32% of SECTORAL ASSET MANAGEMENT's stock portfolio.
- Added to shares of these 10 stocks: JNJ (+$42.64M), NVS (+$35.08M), TEVA (+$24.19M), Mylan Nv (+$23.81M), EW (+$18.86M), K2m Group Holdings (+$13.97M), Endo International (+$8.15M), Aerie Pharmaceuticals (+$6.99M), IART (+$5.62M), MASI.
- Started 17 new stock positions in Tg Therapeutics, MASI, Loxo Oncology, Corvus Pharmaceuticals, La Jolla Pharmaceuticl Com Par, EW, Obseva Sa, NVS, CLDX, REGN. Endo International, Sierra Oncology, Albireo Pharma, ILMN, TEVA, JNJ, Mylan Nv.
- Reduced shares in these 10 stocks: LLY (-$53.63M), Portola Pharmaceuticals (-$31.95M), Global Blood Therapeutics In (-$28.75M), CI (-$28.34M), Kite Pharma (-$24.23M), , PFE (-$21.04M), CELG (-$20.15M), BIIB (-$20.00M), ACAD (-$17.38M).
- Sold out of its positions in AET, Pronai Therapeutics, CI, Entellus Medical Cm, Intercept Pharmaceuticals In, LLY, Surgical Care Affiliates.
- SECTORAL ASSET MANAGEMENT was a net seller of stock by $191.55M.
- SECTORAL ASSET MANAGEMENT has $856.29M in assets under management (AUM), dropping by -5.14%.
SECTORAL ASSET MANAGEMENT portfolio companies for March 2017 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Price | Last Trade |
|---|---|---|---|---|
| Merck & Co (MRK) | 5.35 | 720982 -25.00% | 63.54 | 63.69 |
| Johnson & Johnson (JNJ) | 4.98 | 342350 NEW | 124.55 | 130.83 |
| Pfizer (PFE) | 4.59 | 1.15M -34.00% | 34.21 | 33.00 |
| Neurocrine Biosciences (NBIX) | 4.30 | 851019 +13.00% | 43.30 | 48.83 |
| Novartis AG (NVS) | 4.10 | 472296 NEW | 74.27 | 84.97 |
| Celgene Corporation (CELG) | 3.95 | 272066 -37.00% | 124.43 | 134.15 |
| ABIOMED (ABMD) | 3.83 | 261691 +4.00% | 125.20 | 142.97 |
| Amicus Therapeutics (FOLD) | 3.59 | 4.31M -15.00% | 7.13 | 13.22 |
| Dex (DXCM) | 3.54 | 357341 -29.00% | 84.73 | 66.49 |
| Shire (SHPGY) | 3.53 | 173679 +9.00% | 174.23 | 0.00 |
| Acadia Healthcare | 3.52 | 691010 -22.00% | 43.60 | 0.00 |
| NuVasive (NUVA) | 3.42 | 391989 -21.00% | 74.68 | 76.90 |
| BioMarin Pharmaceutical (BMRN) | 3.23 | 315233 -35.00% | 87.78 | 87.32 |
| Teladoc | 3.09 | 1.06M -32.00% | 25.00 | 0.00 |
| Teva Pharmaceutical Industries (TEVA) | 2.82 | 753821 NEW | 32.09 | 32.45 |
| Mylan Nv | 2.78 | 610743 NEW | 38.99 | 0.00 |
| Portola Pharmaceuticals | 2.76 | 604041 -57.00% | 39.19 | 0.00 |
| ACADIA Pharmaceuticals (ACAD) | 2.69 | 671113 -42.00% | 34.38 | 29.47 |
| Intuitive Surgical (ISRG) | 2.57 | 28672 -32.00% | 766.46 | 931.85 |
| Edwards Lifesciences (EW) | 2.20 | 200479 NEW | 94.07 | 116.36 |
| Wright Medical Group Nv | 2.11 | 581222 +26.00% | 31.12 | 0.00 |
| Aerie Pharmaceuticals | 2.06 | 389423 +65.00% | 45.35 | 0.00 |
| K2m Group Holdings | 2.00 | 836520 +438.00% | 20.51 | 0.00 |
| Alder Biopharmaceuticals | 1.73 | 713119 +6.00% | 20.80 | 0.00 |
| NxStage Medical (NXTM) | 1.58 | 504568 -43.00% | 26.83 | 23.37 |
| Neuroderm Ltd F | 1.52 | 489267 +10.00% | 26.55 | 0.00 |
| Collegium Pharmaceutical Inc Common Stock Usd | 1.50 | 1.28M -39.00% | 10.06 | 0.00 |
| Global Blood Therapeutics In | 1.49 | 345582 -69.00% | 36.85 | 0.00 |
| Accuray Incorporated (ARAY) | 1.38 | 2.48M -19.00% | 4.75 | 4.40 |
| Integra LifeSciences Holdings (IART) | 1.00 | 202499 +192.00% | 42.13 | 50.11 |
| Endo International | 0.95 | 730150 NEW | 11.16 | 0.00 |
| Prothena | 0.92 | 141046 +14.00% | 55.79 | 0.00 |
| Envision Healthcare | 0.90 | 125050 | 61.32 | 0.00 |
| Novo Nordisk A/S (NVO) | 0.87 | 217480 -7.00% | 34.28 | 41.49 |
| Advaxis | 0.80 | 839774 +21.00% | 8.17 | 0.00 |
| Momenta Pharmaceuticals (MNTA) | 0.72 | 460300 +21.00% | 13.35 | 16.30 |
| Masimo Corporation (MASI) | 0.58 | 53300 NEW | 93.26 | 95.53 |
| Kite Pharma | 0.58 | 63520 -82.00% | 78.49 | 0.00 |
| Ra Pharmaceuticals | 0.56 | 225340 -10.00% | 21.29 | 0.00 |
| Dbv Technologies S A | 0.55 | 133499 +247.00% | 35.22 | 0.00 |
| Loxo Oncology | 0.44 | 90390 NEW | 42.08 | 0.00 |
| Molina Healthcare (MOH) | 0.43 | 81575 -40.00% | 45.60 | 68.71 |
| Ptc Therapeutics I | 0.40 | 351135 +185.00% | 9.84 | 0.00 |
| Acceleron Pharma | 0.39 | 126400 -63.00% | 26.47 | 0.00 |
| Biogen Idec (BIIB) | 0.37 | 11711 -86.00% | 273.42 | 287.95 |
| Agios Pharmaceuticals | 0.35 | 51200 -6.00% | 58.40 | 0.00 |
| Intersect Ent | 0.29 | 143240 -73.00% | 17.15 | 0.00 |
| Incyte Corporation (INCY) | 0.27 | 17145 -50.00% | 133.68 | 132.72 |
| La Jolla Pharmaceuticl Com Par | 0.27 | 78700 NEW | 29.85 | 0.00 |
| Regeneron Pharmaceuticals (REGN) | 0.26 | 5695 NEW | 387.53 | 508.41 |
| Illumina (ILMN) | 0.23 | 11350 NEW | 170.66 | 174.33 |
| Insmed Inc | 0.23 | 110599 +7.00% | 17.51 | 0.00 |
| Tg Therapeutics | 0.19 | 137500 NEW | 11.65 | 0.00 |
| Corvus Pharmaceuticals | 0.16 | 67200 NEW | 20.77 | 0.00 |
| Dr. Reddy's Laboratories (RDY) | 0.15 | 32155 | 40.15 | 38.30 |
| Alnylam Pharmaceuticals (ALNY) | 0.15 | 24899 +25.00% | 51.25 | 79.70 |
| Avexis | 0.13 | 14950 -35.00% | 76.05 | 0.00 |
| Celldex Therapeutics (CLDX) | 0.11 | 253178 NEW | 3.61 | 2.30 |
| Sarepta Therapeutics | 0.10 | 28799 | 29.58 | 0.00 |
| Sage Therapeutics | 0.10 | 12199 -56.00% | 71.07 | 0.00 |
| Trillium Therapeutics, Inc. Cmn | 0.09 | 128272 +28.00% | 6.15 | 0.00 |
| Obseva Sa | 0.09 | 75500 NEW | 10.41 | 0.00 |
| Albireo Pharma | 0.06 | 20224 NEW | 23.98 | 0.00 |
| Profound Medical | 0.05 | 495900 | 0.78 | 0.00 |
| Sierra Oncology | 0.04 | 201660 NEW | 1.53 | 0.00 |
Download CSV 
Past 13F-HR SEC Filings for SECTORAL ASSET MANAGEMENT
- SECTORAL ASSET MANAGEMENT 2016 Q4 filed Feb. 10, 2017
- SECTORAL ASSET MANAGEMENT 2016 Q3 filed Nov. 10, 2016
- SECTORAL ASSET MANAGEMENT 2016 Q2 filed Aug. 12, 2016
- SECTORAL ASSET MANAGEMENT 2016 Q1 filed May 13, 2016
- SECTORAL ASSET MANAGEMENT 2015 Q4 filed Feb. 12, 2016
- SECTORAL ASSET MANAGEMENT 2015 Q3 filed Nov. 13, 2015
- SECTORAL ASSET MANAGEMENT 2015 Q2 filed Aug. 13, 2015
- SECTORAL ASSET MANAGEMENT 2015 Q1 filed May 14, 2015
- SECTORAL ASSET MANAGEMENT 2014 Q4 filed Feb. 13, 2015
- SECTORAL ASSET MANAGEMENT 2014 Q3 filed Nov. 13, 2014
- SECTORAL ASSET MANAGEMENT 2014 Q2 filed Aug. 14, 2014
- SECTORAL ASSET MANAGEMENT 2014 Q1 filed May 14, 2014
- SECTORAL ASSET MANAGEMENT 2013 Q4 filed Feb. 12, 2014
- SECTORAL ASSET MANAGEMENT 2013 Q3 filed Nov. 13, 2013
- SECTORAL ASSET MANAGEMENT 2013 Q2 filed Aug. 12, 2013
- Sectoral Asset Management 2013 Q1 filed May 14, 2013
- Sectoral Asset Management 2012 Q4 filed Feb. 14, 2013
- Sectoral Asset Management 2012 Q3 filed Nov. 13, 2012
- Sectoral Asset Management 2012 Q2 filed Aug. 13, 2012